カテゴリ： GlobalData, アメリカ, 企業調査

Bio-Rad Laboratories Inc (BIO)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Bio-Rad Laboratories Inc (BIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011725
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月13日
◆ページ数：76
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Bio-Rad Laboratories Inc (Bio-Rad) develops and manufactures specialty chemicals for use in biochemical, pharmaceutical and other life science research applications. The company offers a comprehensive range of reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. It offers these products to hospitals, clinical laboratories, universities, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food producers. The company offers its products and services to its clients though a global network of subsidiaries. The company operates in North America, Europe, Asia, the Middle East and Africa. Bio-Rad is headquartered in California, the US.

Bio-Rad Laboratories Inc (BIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Bio-Rad Laboratories Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Bio-Rad Laboratories Inc, Medical Equipment, Deal Details 14
Asset Purchase 14
Bio-Rad Labs Acquires Flow Cytometer from Propel Labs 14
Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 15
Venture Financing 16
Oxford Impedance Diagnostics Raises USD2.6 Million in Seed Financing 16
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 17
RainDance Technologies Raises US$35 Million In Venture Financing 18
RainDance Technologies Raises US$20 Million In Series E Financing 19
RainDance Technologies Secures US$37.5 Million In Series D Financing 21
Partnerships 22
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 22
AbD Serotec Enters Into Licensing Agreement With Proteomika 23
Bio-Rad Laboratories Enters into Partnership with Illumina 24
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 25
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 26
Bio-Rad Labs Enters Into Co-Development Agreement With Inpeco 27
Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 28
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 29
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 30
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 31
GnuBIO Enters Into Co-Development Agreement With Montreal Heart Institute 32
Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 33
RainDance Technologies Enters Into Collaboration With Sony DADC 34
RainDance Technologies Enters Into Collaboration With Ambry Genetics 35
RainDance Technologies Enters Into Collaboration With 454 Life Sciences 36
Axis-Shield Signs Option Agreement With Bio-Rad Labs 37
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 38
Equity Offering 39
RainDance Withdraws IPO for USD60 Million 39
Asset Transactions 40
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 40
Acquisition 41
Bio-Rad Labs to Acquire RainDance Technologies 41
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 42
Bio-Rad Labs Acquires QuantaLife For US$162 Million 44
Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For US$0.2 Million 45
Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For US$3.4 Million 46
Bio-Rad Laboratories Inc – Key Competitors 47
Bio-Rad Laboratories Inc – Key Employees 48
Bio-Rad Laboratories Inc – Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 53
Financial Announcements 53
Nov 02, 2017: Bio-Rad Reports Third-Quarter 2017 Financial Results 53
Aug 03, 2017: Bio-Rad Reports Second-Quarter 2017 Financial Results 54
May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 55
Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 56
Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 57
Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 59
Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 61
Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 62
May 05, 2016: Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent 63
Feb 25, 2016: Bio-Rad Reports Fourth-Quarter and Full-Year 2015 Financial Results 64
Corporate Communications 66
Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 66
Product News 67
Jun 08, 2017: Bio-Rad Launches CFX Maestro Software for Real-Time PCR Data Analysis 67
Apr 03, 2017: 2017 AACR Annual Meeting Presentations Highlight the Use of Bio-Rad’s Droplet Digital PCR Technology for Liquid Biopsies in Cancer Research 68
Jan 23, 2017: Liquid biopsy researchers to share their strategies for pairing digital PCR and next-generation sequencing at Precision Medicine World Conference 70
Jan 09, 2017: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases 72
02/25/2016: Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic 73
Product Approvals 74
Feb 25, 2016: Bio-Rad Announces CE IVD Marking of Its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic 74
Other Significant Developments 75
Feb 08, 2016: Bio-Rad Expands its Cell Biology Portfolio with High Performance Flow Cytometer 75
Appendix 76
Methodology 76
About GlobalData 76
Contact Us 76
Disclaimer 76

List of Tables
Bio-Rad Laboratories Inc, Medical Equipment, Key Facts, 2016 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
Bio-Rad Laboratories Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
Bio-Rad Laboratories Inc, Deals By Market, 2011 to YTD 2017 10
Bio-Rad Laboratories Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Bio-Rad Labs Acquires Flow Cytometer from Propel Labs 14
Bio-Rad Labs Acquires Cell Sorting System From Propel Labs 15
Oxford Impedance Diagnostics Raises USD2.6 Million in Seed Financing 16
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 17
RainDance Technologies Raises US$35 Million In Venture Financing 18
RainDance Technologies Raises US$20 Million In Series E Financing 19
RainDance Technologies Secures US$37.5 Million In Series D Financing 21
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 22
AbD Serotec Enters Into Licensing Agreement With Proteomika 23
Bio-Rad Laboratories Enters into Partnership with Illumina 24
RainDance Technologies Enters into Research Agreement with Blood Systems Research Institute 25
Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 26
Bio-Rad Labs Enters Into Co-Development Agreement With Inpeco 27
Bio-Rad Labs Enters Into Co-Marketing Agreement With Lamprogen For Fluorescent Particles 28
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 29
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 30
Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 31
GnuBIO Enters Into Co-Development Agreement With Montreal Heart Institute 32
Bio-Rad Expands Co-Marketing Agreement With Siemens Medical 33
RainDance Technologies Enters Into Collaboration With Sony DADC 34
RainDance Technologies Enters Into Collaboration With Ambry Genetics 35
RainDance Technologies Enters Into Collaboration With 454 Life Sciences 36
Axis-Shield Signs Option Agreement With Bio-Rad Labs 37
Bio-Rad Labs Enters into Licensing agreement with Globavir Biosciences 38
RainDance Withdraws IPO for USD60 Million 39
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 40
Bio-Rad Labs to Acquire RainDance Technologies 41
Bio-Rad Labs Completes Acquisition Of AbD Serotec From MorphoSys For US$70 Million 42
Bio-Rad Labs Acquires QuantaLife For US$162 Million 44
Bio-Rad Labs Acquires Remaining Stake In DiaMed Thailand For US$0.2 Million 45
Bio-Rad Labs Acquires Additional 39% Stake In DiaMed Spain For US$3.4 Million 46
Bio-Rad Laboratories Inc, Key Competitors 47
Bio-Rad Laboratories Inc, Key Employees 48
Bio-Rad Laboratories Inc, Other Locations 49
Bio-Rad Laboratories Inc, Subsidiaries 50

★海外企業調査レポート[Bio-Rad Laboratories Inc (BIO)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Shields Bag And Printing Company
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nippon Flour Mills Co Ltd (2001)：企業の財務・戦略的SWOT分析
    Nippon Flour Mills Co Ltd (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hooper Holmes Inc (HH)-製薬・医療分野：企業M&A・提携分析
    Summary Hooper Holmes Inc (Hooper Holmes) is a provider of health and screening services. The company provides health services such as individual screenings at home or work, onsite screenings for small and large companies, remote screenings for individuals and eligible family members, convenient wal …
  • Stanbic Ibtc Holdings Plc
    Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • 4P-Pharma SAS：製薬・医療：M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Lee’s Pharmaceutical Holdings Ltd (950)：企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • SINTX Technologies Inc (SINT)
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Melkior Resources Inc. (MKR)：企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Corcept Therapeutics Inc (CORT)：企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Neurim Pharmaceuticals Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Neurim Pharmaceuticals Ltd (Neurim) is a drug discovery company that develops drugs for central nervous system diseases.The company's product line includes circadin that is used in insomnia treatment. Neurim offers paediatric prolonged-release melatonin, piromelatine, NEU-P12 and NEU-240. Th …
  • Robinson Helicopter Company, Inc.：企業の戦略・SWOT・財務分析
    Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • MOL Hungarian Oil and Gas PLC (MOL)-エネルギー分野：企業M&A・提携分析
    Summary MOL Hungarian Oil and Gas Public Limited Company (MOL) is an integrated oil and gas company. It explores develops and produces crude oil, natural gas. It conducts refining, transportation and storage of crude oil; wholesale and retail marketing of crude oil products, production and sale of p …
  • First Electric Cooperative Corporation：発電所・企業SWOT分析
    First Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Donaldson Co Inc (DCI)：企業の財務・戦略的SWOT分析
    Donaldson Co Inc (DCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Babcock Power Inc：企業の戦略的SWOT分析
    Babcock Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • General Dynamics United Kingdom Limited：企業の戦略・SWOT・財務情報
    General Dynamics United Kingdom Limited - Strategy, SWOT and Corporate Finance Report Summary General Dynamics United Kingdom Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • RP Management LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary RP Management LLC (RP Management) is a life sciences financing company that offers biopharmaceutical products. The company’s products include thalomid, myozyme, lexiscan, rituxan, atripla, lyrica, prezista, letairis, januvia, onglyza, neupogen, rotateq, cubicin, savella, and others. It also …
  • KNM Group Bhd (KNM)：石油・ガス：M&Aディール及び事業提携情報
    Summary KNM Group Bhd (KNM Group) is a manufacturer of custom designed process equipment's and modular systems. The company's product portfolio includes gas waste heat recovery systems, process and pressure vessels, quench coolers, scraped surface exchangers, heat transfer equipment, membrane techno …
  • Greggs Plc：企業の戦略・SWOT・財務情報
    Greggs Plc - Strategy, SWOT and Corporate Finance Report Summary Greggs Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Spectris plc：企業の戦略・SWOT・財務情報
    Spectris plc - Strategy, SWOT and Corporate Finance Report Summary Spectris plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆